| Dr William Edward Wear, MD | |
|
386 Ben Bolt Ave, Tazewell, VA 24651-2465 | |
| (276) 979-9899 | |
| (276) 979-9798 |
| Full Name | Dr William Edward Wear |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 386 Ben Bolt Ave, Tazewell, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861424392 | NPI | - | NPPES |
| 0107371001 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 20350 (West Virginia) | Primary |
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
University of Colorado Boulder researchers have discovered a brain signature that identifies fibromyalgia sufferers with 93 percent accuracy, a potential breakthrough for future clinical diagnosis and treatment of the highly prevalent condition.
Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today provided an update on the clinical development program for its proprietary product for non-muscle-invasive bladder cancer - Urocidin.
OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that the company has received Clinical Laboratory Improvement Act (CLIA) certification for their newly constructed state-of-the-art molecular diagnostics laboratory.
"It's not much of a surprise that Monday night's presidential debate, which focused on foreign policy, was consumed by a discussion of defense spending, and security and trade policies," but "it's still disappointing that both President Barack Obama and Republican presidential nominee Gov. Mitt Romney were relatively silent on issues like global health, research, and international aid," Global Health Technologies Coalition (GHTC) Communications Officer Kim Lufkin writes in the GHTC's "Breakthroughs" blog.
› Verified 9 days ago
| Entity Name | University Healthcare Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659625739 PECOS PAC ID: 8325291404 Enrollment ID: O20130124000127 |
News Archive
University of Colorado Boulder researchers have discovered a brain signature that identifies fibromyalgia sufferers with 93 percent accuracy, a potential breakthrough for future clinical diagnosis and treatment of the highly prevalent condition.
Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today provided an update on the clinical development program for its proprietary product for non-muscle-invasive bladder cancer - Urocidin.
OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that the company has received Clinical Laboratory Improvement Act (CLIA) certification for their newly constructed state-of-the-art molecular diagnostics laboratory.
"It's not much of a surprise that Monday night's presidential debate, which focused on foreign policy, was consumed by a discussion of defense spending, and security and trade policies," but "it's still disappointing that both President Barack Obama and Republican presidential nominee Gov. Mitt Romney were relatively silent on issues like global health, research, and international aid," Global Health Technologies Coalition (GHTC) Communications Officer Kim Lufkin writes in the GHTC's "Breakthroughs" blog.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Edward Wear, MD Po Box 729, Saltville, VA 24370-0729 Ph: (276) 496-4492 | Dr William Edward Wear, MD 386 Ben Bolt Ave, Tazewell, VA 24651-2465 Ph: (276) 979-9899 |
News Archive
University of Colorado Boulder researchers have discovered a brain signature that identifies fibromyalgia sufferers with 93 percent accuracy, a potential breakthrough for future clinical diagnosis and treatment of the highly prevalent condition.
Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today provided an update on the clinical development program for its proprietary product for non-muscle-invasive bladder cancer - Urocidin.
OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that the company has received Clinical Laboratory Improvement Act (CLIA) certification for their newly constructed state-of-the-art molecular diagnostics laboratory.
"It's not much of a surprise that Monday night's presidential debate, which focused on foreign policy, was consumed by a discussion of defense spending, and security and trade policies," but "it's still disappointing that both President Barack Obama and Republican presidential nominee Gov. Mitt Romney were relatively silent on issues like global health, research, and international aid," Global Health Technologies Coalition (GHTC) Communications Officer Kim Lufkin writes in the GHTC's "Breakthroughs" blog.
› Verified 9 days ago